Selbyville, Delaware, Dec. 07, 2020 (GLOBE NEWSWIRE) — As per credible estimations, global gene therapy market size was worth USD 1221.84 million in the year 2019 and is slated to witness noteworthy expansion during the forecast period 2020-2025.
The sudden emergence of the Covid-19 pandemic has weakened the global economy, impeding revenue generation and market expansion by disruption of the supply chain. The detailed study aims to respond to all client queries and suggests business tactics for stakeholders to adapt to the industry fluctuations. Moreover, the report offers a comprehensive analysis of prominent companies alongside their product offerings, manufacturing capabilities, and profit stake.
Research analysts claim that rising prevalence of chronic diseases such as sickle cell disease, Alzheimer’s, neurological and cardiovascular disorders, and cancer coupled with rising investments in the business sphere are bolstering the expansion of the overall market.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/3056138/
Additionally, technological advancements, growing efforts by industry players towards introducing innovative products, and mergers, acquisitions, and other strategic alliances by biopharmaceutical companies as well as research institutes are positively swaying the global gene therapy market dynamics.
Outlining market segmentations
Based on vector type, global gene therapy industry is bifurcated into lentivirus, retrovirus & gammaretrovirus, AAV (adeno-associated virus), and others. Among these, the AAV segment is expected to account for a majority of the overall market share during the analysis timeframe. Rising prevalence of chronic diseases across the globe, increasing investments by researchers, and escalating research & development activities towards strategically selected cell targets are fostering the growth of the segment.
Speaking of application spectrum, the market is fragmented into cardiovascular disorders, cancer, neurological disorders, mesothelioma, sickle cell disorders, Alzheimer’s disease, and others.
Regional outlook
From a regional frame of reference, global gene therapy market is segmented into Asia-Pacific, North America, and Europe. The country wise fragmentation of the business comprises of South Korea, India, China, Japan, Canada, U.S., Italy, United Kingdom, France, and Germany.
According to the geographic analysis contained in the report, Asia-Pacific and Europe are anticipated to emerge as major growth avenues for the overall industry over 2020-2025. Factors such as growing focus of manufacturers towards the expansion of product pipeline, rising investments by industry partakers towards adoption of advanced technologies, and high concentration of prominent organizations such as Spark Therapeutics, Inc. and Voyager Therapeutics, Inc. are propelling the expansion of the market in the regions.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
Competitive dashboard
Prominent organizations that influence the global gene therapy industry trends are Sarepta Therapeutics, Inc., bluebird bio, Inc., Akcea Therapeutics, Inc., AnGes, Inc., Alnylam Pharmaceuticals Inc., Orchard Therapeutics PLC, MolMed S.p.A., Spark Therapeutics Inc., Novartis AG, and Voyager Therapeutics, Inc. among others.
Global Gene Therapy Market Vector Type Sub-segments (Revenue, USD Million, 2015-2025)
- Lentivirus
- AAV (adeno-associated virus)
- Retrovirus & gammaretrovirus
- Others
Global Gene Therapy Market Application Spectrum (Revenue, USD Million, 2015-2025)
- Alzheimer’s disease
- Sickle cell disorder
- Mesothelioma
- Neurological disorders
- Cancer
- Cardiovascular disorders
- Others
Global Gene Therapy Market Regional Outlook (Revenue, USD Million, 2015-2025)
Asia-Pacific
- South Korea
- India
- China
- Japan
North America
Europe
- Italy
- United Kingdom
- France
- Germany
Global Gene Therapy Market Competitive Landscape (Revenue, USD Million, 2015-2025)
- Sarepta Therapeutics, Inc
- bluebird bio, Inc
- Akcea Therapeutics, Inc
- AnGes, Inc
- Alnylam Pharmaceuticals Inc
- Orchard Therapeutics PLC
- MolMed S.p.A.
- Spark Therapeutics Inc.
- Novartis AG
- Voyager Therapeutics, Inc.
- Others
Table of Contents:
1. Research Methodology and Executive Summary
1.1 Research Methodology
1.2 Executive Summary
2. Strategic Recommendations
3. Gene Therapy Market: Product Outlook
4. Global Gene Therapy Market: Sizing and Forecast
4.1 Market Size, By Value, Year 2015-2025
5. Global Gene Therapy Market Segmentation – By Vector Type, and By Application
5.1 Competitive Scenario of Global Gene Therapy Market: By Vector Type
5.1.1 Lentivirus – Market Size and Forecast (2015-2025)
5.1.2 AAV – Market Size and Forecast (2015-2025)
5.1.3 Retrovirus & Gammaretrovirus – Market Size and Forecast (2015-2025)
5.1.4 Others – Market Size and Forecast (2015-2025)
5.2 Competitive Scenario of Global Gene Therapy Market: By Application
5.2.1 Neurological Disorders – Market Size and Forecast (2015-2025)
5.2.2 Cancer – Market Size and Forecast (2015-2025)
5.2.3 Cardiovascular Diseases – Market Size and Forecast (2015-2025)
6. Global Gene Therapy Market: Regional Analysis
6.1 Competitive Scenario of Global Gene Therapy Market: By Region
7. North America Gene Therapy Market: An Analysis (2015-2025)
7.1 North America Gene Therapy Market: Size and Forecast (2015-2025), By Value
7.2 North America Gene Therapy Market – Prominent Companies
7.3 Market Segmentation By Vector Type (Lentivirus, AAV, Retrovirus & Gammaretrovirus and Others)
7.4 Market Segmentation By Application (Neurological Disorders, Cancer, Cardiovascular Diseases and Others)
7.5 North America Gene Therapy Market: Country Analysis
8. Europe Gene Therapy Market: An Analysis (2015-2025)
8.1 Europe Gene Therapy Market: Size and Forecast (2015-2025), By Value
8.2 Europe Gene Therapy Market – Prominent Companies
8.3 Market Segmentation By Vector Type (Lentivirus, AAV, Retrovirus & Gammaretrovirus and Others)
8.4 Market Segmentation By Application (Neurological Disorders, Cancer, Cardiovascular Diseases and Others)
8.5 Europe Gene Therapy Market: Country Analysis
9. Asia Pacific Gene Therapy Market: An Analysis (2015-2025)
9.1 Asia Pacific Gene Therapy Market: Size and Forecast (2015-2025), By Value
9.2 Asia Pacific Gene Therapy Market – Prominent Companies
9.3 Market Segmentation By Vector Type (Lentivirus, AAV, Retrovirus & Gammaretrovirus and Others)
9.4 Market Segmentation By Application (Neurological Disorders, Cancer, Cardiovascular Diseases and Others)
9.5 Asia Pacific Gene Therapy Market: Country Analysis
10. Global Gene Therapy Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends
11. Market Attractiveness
11.1 Market Attractiveness Chart of Global Gene Therapy Market – By Vector Type, 2025
11.2 Market Attractiveness Chart of Global Gene Therapy Market – By Application, 2025
11.3 Market Attractiveness Chart of Global Gene Therapy Market – By Region, 2025
12. Competitive Landscape
Related Report:
Gene Editing Market Size, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026
Gene Editing Market size is expected to witness 14.9% CAGR from 2020 to 2026, as per new research report. Increasing advancements in gene editing technologies are anticipated to boost the market demand. Growing awareness regarding availability of genetically modified crops and animals will have positive impact on the overall market revenue. Growing utilization of synthetic genes in incorporating newer biosynthetic pathway in microorganisms to manufacture biologics will escalate the market growth. CRISPR-Cas9 is one of the most efficient and inexpensive system used for genome editing. The functions of CRISPR along with other related genes is important in adaptive immunity in selective archaea and bacteria. It further enables organism to respond to and remove any invading genetic material.
About US:
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company’s core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.
Contact Us: Corporate Sales, Market Study Report LLC Phone: 1-302-273-0910 Toll Free: 1-866-764-2150 Email: [email protected] News: http://business-newsupdate.com/
